We have observed a lower intramuscular myostatin in the T2D rats (HFD) than CON, which were aligned with others who have reported a lower myostatin in mice injected with STZ [58] and in T2D patients [25]. This evidence concerns the gene MSTN and type 2 diabetes mellitus.